Expression of cyclin D1 and GSK-3β and their predictive value of prognosis in squamous cell carcinomas of the tongue
- 30 September 2002
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 38 (6) , 549-556
- https://doi.org/10.1016/s1368-8375(01)00121-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasiasOral Oncology, 2001
- Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expressionJournal of Oral Pathology & Medicine, 2000
- Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinomaOral Oncology, 2000
- Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinomaOncogene, 1999
- Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localizationGenes & Development, 1998
- Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinomaInternational Journal of Cancer, 1997
- Correlation between p53 mutation and cyclin D1 amplification in head and neck squamous cell carcinomaOral Oncology, 1997
- Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpressionCancer, 1997
- PRAD-1 (CCND1)/Cyclin D1 oncogene amplification in primary head and neck squamous cell carcinomaCancer, 1994
- Histologic Classification and Grading of Malignancy in Carcinoma of the LarynxActa Radiologica: Therapy, Physics, Biology, 1973